Search - tctmd.com

Displaying 41 - 60 of 2311

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Presenter: Ravjot Singh Bhatia

October 27, 2025

Presentation TCT 2025

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Presenter: Mounica Vorla

October 27, 2025

Presentation TCT 2025

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

Presenter: Muhammad Majid

October 27, 2025

Presentation TCT 2025

TCT 893: Identification of Injured Myocardium in Chronic Coronary Syndromes Using Activated-Fibroblasts Imaging: A Prospective, Proof-of-Concept Study

Presenter: Shengwen Yang

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Presenter: Tomasz Skowerski

October 27, 2025

Presentation TCT 2025

TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial

Presenter: Seunghan Lee

October 27, 2025

Presentation TCT 2025

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

First-in-Human Evaluation of the Zenith LAAO System for Stroke Prevention in High-Risk Atrial Fibrillation Patients (AuriGen)

Presenter: Felix Mahfoud

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Presenter: Usman Baber

October 26, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation TCT 2025

TCT 1351: Severe Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: A Case of Successful Quadruple Pulmonary Vein Stenting

Presenter: Karolina Jasinska-Gniadzik

October 25, 2025

News Conference News EACTS 2025

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Yael L. Maxwell

October 16, 2025

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

TCT 893: Identification of Injured Myocardium in Chronic Coronary Syndromes Using Activated-Fibroblasts Imaging: A Prospective, Proof-of-Concept Study

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

First-in-Human Evaluation of the Zenith LAAO System for Stroke Prevention in High-Risk Atrial Fibrillation Patients (AuriGen)

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

TCT 1351: Severe Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: A Case of Successful Quadruple Pulmonary Vein Stenting

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content